Cargando…

Hepatitis following famotidine: a case report

H2 receptor antagonists can rarely cause idiosyncratic drug reactions leading to acute hepatitis. Famotidine, however, is considered a relatively safe drug with regards to hepatotoxicity. We report a case of a 47 year old male with a history of hepatitis C who developed acute hepatitis on the third...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Nishant, Patel, Chirag, Panda, Mukta
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2640350/
https://www.ncbi.nlm.nih.gov/pubmed/19173722
http://dx.doi.org/10.1186/1757-1626-2-89
_version_ 1782164560191422464
author Gupta, Nishant
Patel, Chirag
Panda, Mukta
author_facet Gupta, Nishant
Patel, Chirag
Panda, Mukta
author_sort Gupta, Nishant
collection PubMed
description H2 receptor antagonists can rarely cause idiosyncratic drug reactions leading to acute hepatitis. Famotidine, however, is considered a relatively safe drug with regards to hepatotoxicity. We report a case of a 47 year old male with a history of hepatitis C who developed acute hepatitis on the third day of hospitalization with a dramatic rise in his liver enzymes from normal values at the time of admission. The acute rise in liver enzymes made us consider an adverse drug reaction and famotidine was discontinued. Subsequently his liver enzymes came back to normal in seven days. Thus, physicians should consider famotidine induced hepatitis as a possible etiology of acute liver dysfunction.
format Text
id pubmed-2640350
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26403502009-02-12 Hepatitis following famotidine: a case report Gupta, Nishant Patel, Chirag Panda, Mukta Cases J Case Report H2 receptor antagonists can rarely cause idiosyncratic drug reactions leading to acute hepatitis. Famotidine, however, is considered a relatively safe drug with regards to hepatotoxicity. We report a case of a 47 year old male with a history of hepatitis C who developed acute hepatitis on the third day of hospitalization with a dramatic rise in his liver enzymes from normal values at the time of admission. The acute rise in liver enzymes made us consider an adverse drug reaction and famotidine was discontinued. Subsequently his liver enzymes came back to normal in seven days. Thus, physicians should consider famotidine induced hepatitis as a possible etiology of acute liver dysfunction. BioMed Central 2009-01-27 /pmc/articles/PMC2640350/ /pubmed/19173722 http://dx.doi.org/10.1186/1757-1626-2-89 Text en Copyright ©2009 Gupta et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Gupta, Nishant
Patel, Chirag
Panda, Mukta
Hepatitis following famotidine: a case report
title Hepatitis following famotidine: a case report
title_full Hepatitis following famotidine: a case report
title_fullStr Hepatitis following famotidine: a case report
title_full_unstemmed Hepatitis following famotidine: a case report
title_short Hepatitis following famotidine: a case report
title_sort hepatitis following famotidine: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2640350/
https://www.ncbi.nlm.nih.gov/pubmed/19173722
http://dx.doi.org/10.1186/1757-1626-2-89
work_keys_str_mv AT guptanishant hepatitisfollowingfamotidineacasereport
AT patelchirag hepatitisfollowingfamotidineacasereport
AT pandamukta hepatitisfollowingfamotidineacasereport